Regulatory change doesn’t announce itself to the people it affects. A rule that matters to your product moves through the Federal Register the same way a hundred rules that don’t move through it, and nobody sends a personal notice saying this one is yours to read.
What’s actually worth tracking
Scope the habit to your own product before you start, rather than trying to read the entire Federal Register or the entire FDA guidance database. In practice that means a saved, narrow search of the Federal Register for proposed and final rules touching the specific CFR parts your product falls under — the same rulemaking process covered mechanically in how a regulation actually changes — and a recurring check of FDA’s guidance document search page for anything new or revised in your device or product area, read with the same care described in how to read FDA guidance. Recognized consensus standards move on their own slower cycle and are worth a separate, occasional check rather than a weekly one.
A routine that survives a busy week
Fifteen to thirty minutes on a fixed day beats an open-ended intention to read “when there’s time,” which in practice becomes never. Log what you find in one line: the date, the exact source and citation, one sentence on whether and how it applies, and a review-by date if it isn’t immediately actionable. The log matters more than the reading did. A finding that isn’t written down somewhere retrievable might as well not have been found, since nobody remembers a notice from four months ago when the question actually comes up in the middle of a submission.
- Date found, and the exact citation — not just a paraphrase of it.
- One sentence: does this apply to what we’re working on, and how.
- The action it triggers, if any — or “none yet” plus a review-by date.
- Who else needs to see it.
Two habits that don’t hold up
Subscribing to everything and reading none of it
A crowded inbox of regulatory alerts creates the feeling of staying current without the substance of it. A narrow, scoped search read consistently beats a wide one read never.
Tracking findings that never reach a decision
A habit that stops at a personal note, with no way to flag it to whoever owns the affected product or file, produces awareness without action — not much better than not tracking at all.
Sources & further reading
- Federal Register federalregister.gov
- FDA — Search FDA Guidance Documents fda.gov
- Regulatory Academy — How a Regulation Actually Changes regulatoryacademy.com
- Regulatory Academy — How to Read FDA Guidance regulatoryacademy.com
This essay is provided for general educational purposes and reflects the regulatory landscape as of its publication date. It is not legal, regulatory, or career advice.
